Massive Bio Collaborates with TOUCH and Navigating Trials to Enhance Cancer Patients' Access to Clinical Trials
Massive Bio, a global precision oncology company, has announced a partnership with TOUCH, The Black Breast Cancer Alliance, and Navigating Trials to improve access to clinical trials for cancer patients. This collaboration will integrate Massive Bio's AI-powered trial matching system into the digital platforms of both organizations, providing a seamless and cost-free pathway for patients to find personalized clinical trial options. TOUCH BBCA focuses on supporting breast cancer patients through education and advocacy, while Navigating Trials extends clinical research opportunities to patients across various cancer types. The partnership aims to bridge the gap between patient communities and the clinical research ecosystem, ensuring equitable access to clinical trials. 
